关于怀孕和哺乳期相关骨质疏松症的当前和未来观点
Nataliya Gak1,2, Ali Abbara2, Waljit S Dhillo2
1Metabolic Bone Unit, Royal National Orthopaedic Hospital NHS Trust, London, United Kingdom.
Frontiers in endocrinology
|December 20, 2024
概括
怀孕和哺乳期相关的骨质疏松症 (PLO) 会导致一些女性的脆弱性骨折. 本综述综合了目前关于PLO发病率,病理生理学和管理的数据,强调需要基于证据的指导方针.
科学领域:
- 骨代谢和内分泌学 骨代谢和内分泌学
- 生殖健康和骨质疏松症
背景情况:
- 怀孕和哺乳期显著改变母亲的骨代谢.
- 虽然这些变化通常是暂时的,但可能导致怀孕和哺乳期相关的骨质疏松症 (PLO) 和脆弱性骨折.
- 在关键的生活阶段,PLO对妇女的生活质量产生了负面影响.
研究的目的:
- 综合有关PLO的发病率,病理生理学和管理的当前数据.
- 提供关于PLO的当前和未来的观点.
- 强调需要基于证据的指导方针,以改善患者的治疗结果.
主要方法:
- 最新可用的数据的小概述.
- 综合来自观察和案例研究的信息.
- 分析风险因素,包括低BMI,青少年体力活动减少,家族病史和遗传变异 (LRP5,WNT1).
主要成果:
- PLO是一种罕见的疾病,人们对其意识有限,了解其机制和治疗方法的进展缓慢.
- 现有的数据主要来自观察和案例研究,缺乏对多学科方法的明确指导.
- 确定的危险因素包括低BMI,家族病史和特定的遗传变异.
结论:
- 迫切需要基于证据的指导方针来有效管理PLO.
- 更好的理解和管理策略对于改善受影响妇女的短期和长期结果至关重要.
- 需要进一步的研究来解决PLO的病理生理学和最佳治疗.
关键词:
骨密度 骨密度 骨密度骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折.哺乳期 哺乳期 哺乳期骨质疏松症是一种骨质疏松症.怀孕 怀孕 怀孕 怀孕 怀孕更多相关视频
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.6K
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
442
相关概念视频
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
What is the Skeletal System?
52.2K
Overview
52.2K
Ovarian Cycle
993
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
993
